Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.

Mangan BL, McAlister RK, Balko JM, Johnson DB, Moslehi JJ, Gibson A, Phillips EJ
Br J Clin Pharmacol. 2020 86 (9): 1778-1789

PMID: 32543711 · PMCID: PMC7444794 · DOI:10.1111/bcp.14433

MeSH Terms (7)

Drug-Related Side Effects and Adverse Reactions Humans Immune Checkpoint Inhibitors Incidence Melanoma Neoplasms Programmed Cell Death 1 Receptor

Connections (1)

This publication is referenced by other Labnodes entities: